(HCSG) Healthcare - Ratings and Ratios
Housekeeping,Laundry,Dietary,Facility,Services
HCSG EPS (Earnings per Share)
HCSG Revenue
Description: HCSG Healthcare August 21, 2025
Healthcare Services Group Inc (HCSG) is a US-based company operating in the Diversified Support Services sub-industry, providing various services to the healthcare sector. The companys stock performance is characterized by a relatively stable price movement, with a beta of 0.538, indicating lower volatility compared to the overall market.
The income tax expense of HCSG is a critical component of its financials, influencing its net income and profitability. Analyzing the yearly income tax expense can provide insights into the companys tax strategy and its impact on earnings. Key drivers of income tax expense include changes in tax laws, the companys geographical footprint, and its operational structure.
To evaluate HCSGs performance, key performance indicators (KPIs) such as revenue growth, operating margin, and return on equity (ROE) are essential. The companys ROE of 2.18% suggests that HCSG may be facing challenges in generating returns for its shareholders. However, its forward P/E ratio of 17.57 indicates that the market expects improved earnings in the future.
Economic drivers influencing HCSGs business include the demand for healthcare services, government policies and regulations, and the overall economic environment. The aging population and the resulting increase in healthcare needs are positive drivers for the company. Conversely, changes in healthcare policies and reimbursement rates can negatively impact HCSGs revenue and profitability.
To assess the companys valuation, metrics such as the price-to-earnings (P/E) ratio and market capitalization are useful. HCSGs market capitalization of $1.092 billion and P/E ratio of 107.79 suggest that the stock may be overvalued, although the forward P/E ratio indicates potential for earnings growth. A comprehensive analysis of HCSGs financials, industry trends, and economic drivers is necessary to determine the companys intrinsic value and investment potential.
HCSG Stock Overview
| Market Cap in USD | 1,260m |
| Sub-Industry | Diversified Support Services |
| IPO / Inception | 1990-03-26 |
HCSG Stock Ratings
| Growth Rating | 35.6% |
| Fundamental | 71.2% |
| Dividend Rating | 9.35% |
| Return 12m vs S&P 500 | 34.6% |
| Analyst Rating | 3.80 of 5 |
HCSG Dividends
Currently no dividends paidHCSG Growth Ratios
| Growth Correlation 3m | 85.2% |
| Growth Correlation 12m | 77.8% |
| Growth Correlation 5y | -69.3% |
| CAGR 5y | 11.03% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.26 |
| CAGR/Mean DD 3y (Pain Ratio) | 0.54 |
| Sharpe Ratio 12m | 0.15 |
| Alpha | 48.98 |
| Beta | 0.699 |
| Volatility | 34.15% |
| Current Volume | 627k |
| Average Volume 20d | 661.7k |
| Stop Loss | 17.3 (-4%) |
| Signal | 0.27 |
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (39.7m TTM) > 0 and > 6% of Revenue (6% = 108.5m TTM) |
| FCFTA 0.20 (>2.0%) and ΔFCFTA 14.96pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 21.29% (prev 22.38%; Δ -1.09pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.20 (>3.0%) and CFO 163.8m > Net Income 39.7m (YES >=105%, WARN >=100%) |
| Net Debt (-118.2m) to EBITDA (72.2m) ratio: -1.64 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.97 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (73.5m) change vs 12m ago -0.57% (target <= -2.0% for YES) |
| Gross Margin 12.49% (prev 16.70%; Δ -4.20pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 224.6% (prev 211.2%; Δ 13.44pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 19.86 (EBITDA TTM 72.2m / Interest Expense TTM 2.80m) >= 6 (WARN >= 3) |
Altman Z'' 5.94
| (A) 0.48 = (Total Current Assets 580.6m - Total Current Liabilities 195.6m) / Total Assets 804.3m |
| (B) 0.31 = Retained Earnings (Balance) 252.4m / Total Assets 804.3m |
| (C) 0.07 = EBIT TTM 55.7m / Avg Total Assets 805.1m |
| (D) 1.25 = Book Value of Equity 252.5m / Total Liabilities 201.9m |
| Total Rating: 5.94 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 71.17
| 1. Piotroski 7.0pt = 2.0 |
| 2. FCF Yield 14.51% = 5.0 |
| 3. FCF Margin 8.73% = 2.18 |
| 4. Debt/Equity 0.01 = 2.50 |
| 5. Debt/Ebitda -1.64 = 2.50 |
| 6. ROIC - WACC (= -0.20)% = -0.25 |
| 7. RoE 7.59% = 0.63 |
| 8. Rev. Trend 87.68% = 6.58 |
| 9. EPS Trend 0.59% = 0.03 |
What is the price of HCSG shares?
Over the past week, the price has changed by -6.24%, over one month by +11.30%, over three months by +30.27% and over the past year by +61.41%.
Is Healthcare a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HCSG is around 18.31 USD . This means that HCSG is currently overvalued and has a potential downside of 1.55%.
Is HCSG a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the HCSG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 22 | 22% |
| Analysts Target Price | 22 | 22% |
| ValueRay Target Price | 20.4 | 13.3% |
HCSG Fundamental Data Overview November 05, 2025
P/E Trailing = 33.1111
P/E Forward = 16.7785
P/S = 0.6966
P/B = 2.5107
P/EG = 2.3893
Beta = 0.699
Revenue TTM = 1.81b USD
EBIT TTM = 55.7m USD
EBITDA TTM = 72.2m USD
Long Term Debt = 8.03m USD (from capitalLeaseObligations, last fiscal year)
Short Term Debt = 8.40m USD (from shortTermDebt, last fiscal year)
Debt = 6.22m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -118.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.09b USD (1.26b + Debt 6.22m - CCE 177.5m)
Interest Coverage Ratio = 19.86 (Ebit TTM 55.7m / Interest Expense TTM 2.80m)
FCF Yield = 14.51% (FCF TTM 157.9m / Enterprise Value 1.09b)
FCF Margin = 8.73% (FCF TTM 157.9m / Revenue TTM 1.81b)
Net Margin = 2.20% (Net Income TTM 39.7m / Revenue TTM 1.81b)
Gross Margin = 12.49% ((Revenue TTM 1.81b - Cost of Revenue TTM 1.58b) / Revenue TTM)
Gross Margin QoQ = 20.76% (prev 0.65%)
Tobins Q-Ratio = 1.35 (Enterprise Value 1.09b / Total Assets 804.3m)
Interest Expense / Debt = 13.08% (Interest Expense 813.0k / Debt 6.22m)
Taxrate = 25.05% (14.4m / 57.3m)
NOPAT = 41.7m (EBIT 55.7m * (1 - 25.05%))
Current Ratio = 2.97 (Total Current Assets 580.6m / Total Current Liabilities 195.6m)
Debt / Equity = 0.01 (Debt 6.22m / totalStockholderEquity, last quarter 602.4m)
Debt / EBITDA = -1.64 (Net Debt -118.2m / EBITDA 72.2m)
Debt / FCF = -0.75 (Net Debt -118.2m / FCF TTM 157.9m)
Total Stockholder Equity = 523.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.94% (Net Income 39.7m / Total Assets 804.3m)
RoE = 7.59% (Net Income TTM 39.7m / Total Stockholder Equity 523.4m)
RoCE = 10.48% (EBIT 55.7m / Capital Employed (Equity 523.4m + L.T.Debt 8.03m))
RoIC = 8.40% (NOPAT 41.7m / Invested Capital 497.1m)
WACC = 8.60% (E(1.26b)/V(1.27b) * Re(8.59%) + D(6.22m)/V(1.27b) * Rd(13.08%) * (1-Tc(0.25)))
Discount Rate = 8.59% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.25%
[DCF Debug] Terminal Value 68.02% ; FCFE base≈109.8m ; Y1≈72.1m ; Y5≈33.0m
Fair Price DCF = 8.40 (DCF Value 591.6m / Shares Outstanding 70.5m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 0.59 | EPS CAGR: 43.15% | SUE: 1.65 | # QB: 1
Revenue Correlation: 87.68 | Revenue CAGR: 3.36% | SUE: 0.66 | # QB: 0
Additional Sources for HCSG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle